Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma

PURPOSE: The aim was to investigate the pharmacokinetics of preoperatively administered intraperitoneal (IP) 5-FU in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by analyzing levels of 5-FU and target metabolites in peritoneal fluid, plasma, liver, lymph nodes, pancreatic tumour,...

Descripción completa

Detalles Bibliográficos
Autores principales: Öman, Mikael, Wettergren, Yvonne, Odin, Elisabeth, Westermark, Sofia, Naredi, Peter, Hemmingsson, Oskar, Taflin, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367903/
https://www.ncbi.nlm.nih.gov/pubmed/34132895
http://dx.doi.org/10.1007/s00280-021-04318-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367903/
https://www.ncbi.nlm.nih.gov/pubmed/34132895
http://dx.doi.org/10.1007/s00280-021-04318-x

Ejemplares similares